Qube Research & Technologies (QRT)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,950	Closed	-$2.19M	–	4397
2023 Q2	$2.19M	Buy	+51,950	New	+$2.1M	0.01%	1015
2022 Q4	–	Sell	-6,378	Closed	-$301K	–	3146
2022 Q3	$301K	Buy	+6,378	New	+$412K	﹤0.01%	1622
2022 Q2	–	Sell	-12,062	Closed	-$976K	–	3279
2022 Q1	$976K	Sell	12,062 -12,997	-52%	-$1.1M	0.01%	1185
2021 Q4	$2.57M	Buy	+25,059	New	+$2.41M	0.02%	756
2021 Q2	–	Sell	-30,807	Closed	-$2.34M	–	2934
2021 Q1	$2.34M	Buy	30,807 +9,551	+45%	+$720K	0.04%	581
2020 Q4	$1.45M	Sell	21,256 -60,286	-74%	-$3.76M	0.02%	745
2020 Q3	$4.33M	Buy	81,542 +45,035	+123%	+$2.68M	0.06%	407
2020 Q2	$2.13M	Buy	+36,507	New	+$1.96M	0.03%	641
2018 Q4	–	Sell	-1,922	Closed	-$99K	–	960
2018 Q3	$99K	Buy	1,922 +1,612	+520%	+$78.9K	0.01%	763
2018 Q2	$15K	Buy	+310	New	+$12.8K	0.01%	740

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SYNH Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 51,950 shares — an estimated $2.19M sold.

Qube Research & Technologies (QRT) first reported a position in SYNH in Q2 2018 and held it in 10 quarters. The position peaked at $4.33M in Q3 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Qube Research & Technologies (QRT) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 51,950 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.19M.
Qube Research & Technologies (QRT) first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s Syneos Health, Inc. Class A Common Stock position peaked at $4.33M in Q3 2020.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.